
Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Prieto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Dermatopathology, 1995 - 1996
- New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 1991 - 1994
- Universidad Central de BarcelonaPhD, Cellular Biology, PhD cum laude, 1989 - 1991
- OtherClass of 1986, MD
Certifications & Licensure
- TX State Medical License 2001 - 2026
- NC State Medical License 1996 - 2006
- American Board of Pathology Anatomic Pathology
- American Board of Pathology Dermatopathology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Publications & Presentations
PubMed
- A Clinical, Morphologic, and Molecular Comparison of Bonafide Spitz Melanomas and ASTs in the Pediatric Population.Haya Mary Beydoun, Julia Edwin Jeyakumar, Afua Addo, Shantel Olivares, Lili Zhao
The American Journal of Surgical Pathology. 2025-04-24 - Nicotinic Acetylcholine Receptor Expression in Merkel Cell Carcinoma Is Associated With Clinical and Histopathologic Parameters.Christopher R Cunningham, Yiannis P Dimopoulos, Ian M García-Quiñones, Denái R Milton, Manuel Delgado-Vélez
Journal of Cutaneous Pathology. 2025-04-01 - BRCA1-Associated Protein-1 Inactivated Melanoma Arising in a Pre-existing Nevus With ALK Fusion and Low Tumor Mutational Burden.Nada Shaker, Robert Phelps, George Niedt, Omar Sangueza, Ramakrishnan Krishnan
The American Journal of Dermatopathology. 2025-04-01
Journal Articles
- Author Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaJanice N Cormier, Ehab Hanna, Padmanee Sharma, Jennifer A Wargo, Isabella C Glitza, Sapna P Patel, Adi Diab, Jeffrey E Lee, Richard Royal, Randal Weber, Patrick Hwu, J..., Nature
- Publisher Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaScott Woodman, Alexander J Lazar, Michael A Davies, Neil Gross, Sapna P Patel, Isabella C Glitza, Ehab Hanna, Stephen Y Lai, Richard Ehlers, Amy Hessel, Padmanee Sharm..., Nature
- Melanoma Coexisting with Solar Elastosis: A Potential Pitfall in the Differential Diagnosis Between Nevus and MelanomaMichael T Tetzlaff, Victor G Prieto, Phyu P Aung, Priyadharsini Nagarajan, ScienceDirect
- Join now to see all
Press Mentions
- Major Pathologic Response to Neoadjuvant Pembrolizumab in Advanced Melanoma Trial Exceeds 50%October 25th, 2023
- Pembrolizumab Trial in Advanced Melanoma Shows Major Pathological Response Exceeding 50%October 25th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: